Erchonia Secures New International Distribution for Zerona
McKinney, TX, March 30, 2011 – Erchonia, the global leader in low level laser healthcare applications, today announces a new distribution partnership with New Medic Co. for Erchonia’s FDA approved Zeronabody-contouring laser. New Medic Co will bring the Zerona laser to new markets including Saudi Arabia, Jordan, Lebanon, Syria, Kuwait, UAE, Oman, Yemen, Qatar, Bahrain and Egypt.
“There is certainly a demand for noninvasive body-contouring technologies,” says Abdulwahab Elkhereiji, general manager of New Medic Co. “We are very impressed with the science behind the Zerona laser and its recent FDA approval.”
“We are excited to be expanding our distribution network with New Medic Co. and hope they will help make our Zerona technology even more readily available world-wide,” adds Steve Shanks, president of Erchonia.
The Zerona protocol consists of six treatments; one forty-minute treatment every other day for two weeks. Zerona is the only device on the market proven effective with a double-blind, multi-site, placebo-controlled study, and is the only non-invasive procedure that guarantees an average of three inches lost in as little as two weeks.
In contrast to high-power and high-heat lasers, Erchonia’s Zerona produces a low-level output that has no thermal effect on the body's tissue. Unlike the majority of other devices on the market, its unique technology does not kill or damage fat cells. Zerona instead creates a pore in each cell for the fat to leak out of and then be processed naturally through the lymphatic system. Zerona is the first painless body contouring procedure to effectively remove excess fat without harming the fat cell.
Zerona’s external application provides results without the dangers associated with invasive weight loss surgery; it’s painless, has no downtime and no negative side effects, allowing patients to remain active during treatment.
For more information, please visit www.erchonia.com.
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit www.erchonia.com.
Susan Woods, Crier Communications, 310-274-1072 x 202 email@example.com